Pathogenesis of the H5N1 avian influenza virus in humans and mammalian models

Future Virology

Volumn 4, Issue 2, 2009, Pages 177-184

  Auewarakul, Prasert ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Apoptosis; Avian influenza; Cytokine; Genetic determinants; H5N1; Hemagglutinin; Human; Mammalian; Pathology; Virulence

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; HEMAGGLUTININ; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VIRUS RECEPTOR;

APOPTOSIS; AVIAN INFLUENZA; CYTOKINE PRODUCTION; HUMAN; INFECTION SENSITIVITY; INFLUENZA VIRUS A H5N1; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PANDEMIC; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AVES; AVIAN INFLUENZA VIRUS; MAMMALIA;

EID: 70349204519     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460794.4.2.177     Document Type: Review

References (98)

1. Steinhauer DA: Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258, 1-20 (1999).
2. Cheung CY, Poon LL, Lau AS et al.: Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360, 1831-1837 (2002).
3. Seo SH, Hoffmann E, Webster RG: Lethal H5N1 influenza viruses escape host antiviral cytokine responses. Nat. Med. 8, 950-954 (2002).
4. Seo SH, Hoffmann E, Webster RG: The NS1 gene of H5N1 influenza viruses circumvents the host antiviral cytokine responses. Virus Res. 103, 107-113 (2004).
5. Uiprasertkul M, Puthavathana P, Sangsiriwut K et al.: Influenza A H5N1 replication sites in humans. Emerg. Infect. Dis. 11, 1036-1041 (2005).
6. Daidoji T, Koma T, Du A et al.: H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells. J. Virol. 82, 11294-11307 (2008).
7. Uiprasertkul M, Kitphati R, Puthavathana P et al.: Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg. Infect. Dis. 13, 708-712 (2007).
8. Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, Lau YL: Functional tumor necrosis factor-related apoptosis-inclucing ligand production by avian influenza virus-infected macrophages. J. Infect. Dis. 193, 945-953 (2006).
9. Thanawongnuwech R, Amonsin A, Tantilertcharoen R et al.: Probable tiger-tiger transmission of avian influenza H5N1. Emerg. Infect. Dis. 11, 699-701 (2005).
10. Keawcharoen J, Oraveerakul K, Kuiken T et al.: Avian influenza H5N1 in tigers and leopards. Emerg. Infect. Dis. 10, 2189-2191 (2004).
11. Kuiken T, Rimmelzwaan G, van Riel D et al.: Avian H5N1 influenza in cats. Science 306, 241 (2004).
12. Smith H, Sweet C: Lessons for human influenza from pathogenicity studies with ferrets. Rev. Infect. Dis. 10, 56-75 (1988).
13. Leigh MW, Connor RJ, Kelm S, Baum LG, Paulson JC: Receptor specificity of influenza virus influences severity of illness in ferrets. Vaccine 13, 1468-1473 (1995).
14. Govorkova EA, Rehg JE, Krauss S et al.: Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol. 79, 2191-2198 (2005).
15. Zitzow LA, Rowe T, Morken T, Shieh WJ, Zaki S, Katz JM: Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J. Virol. 76, 4420-4429 (2002).
16. Yen HL, Lipatov AS, Ilyushina NA et al.: Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J. Virol. 81, 6896-6898 (2007).
17. Maines TR, Chen LM, Matsuoka Y et al.: Lack, of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl. Acad. Sci. USA 103, 12121-12126 (2006).
18. Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD: A primate model to study the pathogenesis of influenza A (H5N1) virus infection. Avian Dis. 47, 931-933 (2003).
19. Kuiken T, Rimmelzwaan GF, van Amerongen G, Osterhaus AD: Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques ( Macaca fascicularis). Vet. Pathol. 40, 304-310 (2003).
20. Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD: Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol. 75, 6687-6691 (2001).
21. Tanaka H, Park CH, Ninomiya A et al.: Neurotropism of the 1997 Hong Kong H5N1 influenza virus in mice. Vet. Microbiol. 95, 1-13 (2003).
22. Lipatov AS, Krauss S, Guan Y et al.: Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001. J. Virol. 77, 3816-3823 (2003).
23. Rowe T, Cho DS, Bright RA, Zitzow LA, Katz JM: Neurological manifestations of avian influenza viruses in mammals. Avian Dis. 47, 1122-1126 (2003).
24. Nishimura H, Itamura S, Iwasaki T, Kurata T, Tashiro M: Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection. J. Gen. Virol. 81, 2503-2510 (2000).
25. Mase M, Tanimura N, Imada T, Okamatsu M, Tsukamoto K, Yamaguchi S: Recent H5N1 avian influenza A virus increases rapidly in virulence to mice after a single passage in mice. J. Gen. Virol. 87, 3655-3659 (2006).
26. Maines TR, Lu XH, Erb SM et al.: Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79, 11788-11800 (2005).
27. Park CH, Ishinaka M, Takada A et al.: The invasion routes of neurovirulent A/Hong Kong/483/97 (H5N1) influenza virus into the central nervous system after respiratory infection in mice. Arch. Virol. 147, 1425-1436 (2002).
28. Iwasaki T, Itamura S, Nishimura H et al.: Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation. Acta Neuropathol. 108, 485-492 (2004).
29. Songserm T, Amonsin A, Jamon R et al.: Fatal avian influenza A H5N1 in a dog. Emerg. Infect. Dis. 12, 1744-1747 (2006).
30. Song D, Kang B, Lee C et al.: Transmission of avian influenza virus (H3N2) to dogs. Emerg. Infect. Dis. 14, 741-746 (2008).
31. Maas R, Tacken M, Ruuls L, Koch G, van Rooij E, Stockhofe-Zurwieden N: Avian influenza (H5N1) susceptibility and receptors in dogs. Emerg. Infect. Dis. 13, 1219-1221 (2007).
32. Choi YK, Nguyen TD, Ozaki H et al.: Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J. Virol. 79, 10821-10825 (2005).
33. Kalthoff D, Hoffmann B, Harder T, Durban M, Beer M: Experimental infection of cattle with highly pathogenic avian influenza virus (H5N1). Emerg. Infect. Dis. 14, 1132-1134 (2008).
34. Gu J, Xie Z, Gao Z et al.: H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370, 1137-1145 (2007).
35. Korteweg C, Gu J: Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol. 172, 1155-1170 (2008).
36. To KF, Chan PK, Chan KF et al.: Pathology of fatal human infection associated with avian influenza A H5N1 virus. J. Med. Virol. 63, 242-246 (2001).
37. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM: H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4, e1000115 (2008).
38. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z et al.: Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med. 358, 261-273 (2008).
39. Apisarnthanarak A, Kitphati R, Thongphubeth K et al.: Atypical avian influenza (H5N1). Emerg, Infect. Dis. 10, 1321-1324 (2004).
40. de Jong MD, Bach VC, Phan TQ et al.: Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med. 352, 686-691 (2005).
41. Stieneke-Grober A, Vey M, Angliker H et al.: Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11, 2407-2414 (1992).
42. Subbarao K, Klimov A, Katz J et al.: Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279, 393-396 (1998).
43. Horimoto T, Ito T, Alexander DJ, Kawaoka Y: Cleavability of hemagglutinin from an extremely virulent strain of avian influenza virus containing a unique cleavage site sequence. J. Vet. Med. Sci. 57, 927-930 (1995).
44. Hulse DJ, Webster RG, Russell RJ, Perez DR: Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens. J. Virol. 78, 9954-9964 (2004).
45. Katz JM, Lu X, Frace AM, Morken T, Zaki SR, Tumpey TM: Pathogenesis of and immunity to avian influenza A H5 viruses. Biomed. Pharmacother. 54, 178-187 (2000).
46. Tumpey TM, Garcia-Sastre A, Taubenberger JK et al.: Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 79, 14933-14944 (2005).
47. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF: Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl Acad. Sci. USA 101, 3166-3171 (2004).
48. Chen H, Bright RA, Subbarao K et al.: Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. Virus Res. 128, 159-163 (2007).
49. Katz JM, Lu X, Tumpey TM, Smith CB, Shaw MW, Subbarao K: Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J. Virol. 74, 10807-10810 (2000).
50. Salomon R, Hoffmann E, Webster RG: Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl Acad. Sci. USA 104, 12479-12481 (2007).
51. de Jong MD: H5N1 transmission and disease: observations from the frontlines. Pediatr. Infect. Dis. J. 27, S54-S56 (2008).
52. de Jong MD, Simmons CP, Thanh TT et al.: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203-1207 (2006).
53. Salomon R, Franks J, Govorkova EA et al.: The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04, J. Exp. Med. 203, 689-697 (2006).
54. Labadie K, Dos Santos Afonso E, Rameix-Welti MA, van der Werf S, Naffakh N: Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells. Virology 362, 271-282 (2007).
55. Hatta M, Gao P, Halfmann P, Kawaoka Y: Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840-1842 (2001).
56. Puthavathana P, Auewarakul P, Charoenying PC et al.: Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J. Gen. Virol. 86, 423-433 (2005).
57. Massin P, van der Werf S, Naffakh N: Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J. Virol. 75, 5398-5404 (2001).
58. Hatta M, Hatta Y, Kim JH et al.: Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog. 3, 1374-1379 (2007).
59. Reuter G, Gabius HJ: Sialic acids structure-analysis-metabolism-occurence-recognition. Biol. Chem. Hoppe-Seyler 377, 325-342 (1996).
60. Suzuki Y: Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull. 28, 399-408 (2005).
61. Rogers GN, Paulson JC: Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127, 361-373 (1983).
62. White MR, Crouch E, van Eijk M et al.: respiratory innate immune proteins and neuraminidase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L831-L840 (2005).
63. Couceiro JN, Paulson JC, Baum LG: Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29, 155-165 (1993).
64. Gagneux P, Cheriyan M, Hurtado-Ziola N et al.: Human-specific regulation of α2-6-linked sialic acids. J. Biol. Chem. 278, 48245-48250 (2003).
65. Shinva K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y: Avian flu: influenza virus receptors in the human airway. Nature 440, 435-436 (2006).
66. Yao L, Korteweg C, Hsueh W, Gu J: Avian influenza receptor expression in H5N1-infected and noninfected human tissues. Faseb J. 22, 733-740 (2008).
67. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W et al.: Human disease from influenza A (H5N1), Thailand, 2004. Emerg. Infect. Dis. 11, 201-209 (2005).
68. Liem NT, Lim W: Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg. Infect. Dis. 11, 210-215 (2005).
69. Apisarnthanarak A, Erb S, Stephenson I et al.: Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clin. Infect. Dis. 40, E16-E18 (2005).
70. Fisman DN: Hemophagocytic syndromes and infection. Emerg. Infect. Dis. 6, 601-608 (2000).
71. Chan MC, Cheung CY, Chui WH et al.: Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6, 135 (2005).
72. Guan Y, Poon LL, Cheung CY et al.: H5N1 influenza: a protean pandemic threat. Proc. Natl Acad. Sci. USA 101, 8156-8161 (2004).
73. Lee DC, Cheung CY, Law AH, Mok CK, Peiris M, Lau AS: p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor α expression in response to avian influenza virus H5N1. J. Virol. 79, 10147-10154 (2005).
74. Cameron CM, Cameron MJ, Bermejo-Martin JF et al.: Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J. Virol. 82, 11308-11317 (2008).
75. Lee SM, Cheung CY, Nicholls JM et al.: Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J. Infect. Dis. 198, 525-535 (2008).
76. Zheng BJ, Chan KW, Lin YP et al.: Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc. Natl Acad. Sci. USA 105, 8091-8096 (2008).
77. Droebner K, Reiling SJ, Planz O: Role of hypercytokinemia in NF-κB p50-deficient mice aftet H5N1 influenza A virus infection. J. Virol. 82, 11461-11466 (2008).
78. Lu Y, Wambach M, Katze MG, Krug RM: Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214, 222-228 (1995).
79. Li S, Min JY, Krug RM, Sen GC: Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349(1), 13-21 (2006).
80. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA: A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc. Natl Acad. Sci. USA 105, 4381-4386 (2008).
81. Obenauer JC, Denson J, Mehra PK et al.: Large-scale sequence analysis of avian influenza isolates. Science 311, 1576-1580 (2006).
82. Jiao P, Tian G, Li Y et al.: A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J. Virol. 82, 1146-1154 (2008).
83. Lowy RJ: Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms. Int. Rev. Immunol. 22, 425-449 (2003).
84. Chen W, Calvo PA, Malide D et al.: A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7, 1306-1312 (2001).
85. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P: Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 1, e4 (2005).
86. Chanturiya AN, Basanez G, Schubert U, Henklein P, Yewdell JW, Zimmerberg J: PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J. Virol. 78, 6304-6312 (2004).
87. Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW: The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J. Virol. 77, 7214-7224 (2003).
88. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P: A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3, 1414-1421 (2007).
89. Rooney SA, Young SL, Mendelson CR: Molecular and cellular processing of lung surfactant. Faseb J. 8, 957-967 (1994).
90. Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S: The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell. Microbiol. 10, 1140-1152 (2008).
91. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA: Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312, 404-410 (2006).
92. Yamada S, Suzuki Y, Suzuki T et al.: Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444, 378-382 (2006).
93. Auewarakul P, Suptawiwat O, Kongchanagul A et al.: An avian influenza H5N1 virus that binds to a human-type receptor. J. Virol. 81, 9950-9955 (2007).
94. Ferguson NM, Cummings DA, Cauchemez S et al.: Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437,209-214 (2005).
95. Longini IM Jr, Nizam A, Xu S et al.: Containing pandemic influenza at the source. Science 309, 1083-1087 (2005).
96. Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH: Estimation of potential global pandemic influenza mortality on the basis of vital. registry data from the 1918-1920 pandemic: a quantitative analysis. Lancet 368, 2211-2218 (2006).
97. Kandun IN, Tresnaningsih E, Purba WH et al.: Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 372, 744-749 (2008).
98. Li KS, Guan Y, Wang J et al.: Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430, 209-213 (2004).